| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1098ad02d77ec119dc0220698c1df234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4aa531f527c1e2f9baeb0dc7db1a1b23 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate |
2002-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63e74bf77f7adaa98f2477eea77d4b9f |
| publicationDate |
2004-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03045399-A3 |
| titleOfInvention |
Composition based on diosgenin ester for topical use |
| abstract |
The invention concerns compositions useful in therapeutics and in cosmetology. The composition comprises a diosgenin ester with linear or branched alkylated ester chain containing 1 to 30 carbon atoms selected preferably among diosgenin lactate and glycolate. The invention is applicable in dermatology by acting on the superficial musculo-aponevrotic system or on estrogen and progesterone cell receptors. |
| priorityDate |
2001-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |